FKBP51 Immunohistochemical Expression: A New Prognostic Biomarker for OSCC?

Up-to-date, several molecular markers of prognosis have been studied in Oral Squamous Cell Carcinoma (OSCC), but none entered in the clinical setting. Therapy of OSCC tumors mainly relies on surgery, radiotherapy and partially on chemotherapy; there is an urgent need for biomarkers able to better st...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Int J Mol Sci
Autores principales: Russo, Daniela, Merolla, Francesco, Mascolo, Massimo, Ilardi, Gennaro, Romano, Simona, Varricchio, Silvia, Napolitano, Virginia, Celetti, Angela, Postiglione, Loredana, Di Lorenzo, Pier Paolo, Califano, Luigi, Dell’Aversana, Giovanni Orabona, Astarita, Fabio, Romano, Maria Fiammetta, Staibano, Stefania
Formato: Artigo
Lenguaje:Inglês
Publicado: MDPI 2017
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5343977/
https://ncbi.nlm.nih.gov/pubmed/28218707
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms18020443
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares